pitolisant: Clinical Trials

5 trials of pitolisant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5

Follow pitolisant: new trials by email Literature Review of pitolisant trials Research Report on pitolisant

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
Pitolisant Oral Tablet, Placebo oral tablet - Myotonic Dystrophy 1, Excessive Daytime Sleepiness
Phase 2CompletedHarmony Biosciences Management, Inc.302021-06-282026-09-04
A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
Pitolisant oral tablets, Placebo oral tablet - Prader-Willi Syndrome
Phase 2CompletedHarmony Biosciences Management, Inc.652020-12-092026-05-12
Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)
BF2.649, Placebo - Obstructive Sleep Apnoea, Excessive Daytime Sleepiness
Phase 2CompletedBioprojet1102010-10-012012-06-15
Study to Demonstrate Cognitive Enhancing Effects of BF2.649
BF2.649, Placebo - Schizophrenia
Phase 2CompletedUniversity of Texas Southwestern Medical Center522008-06-012019-04-23
Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease Patients
Placebo, BF 2.649 5 mg, BF 2.649 10 mg - Excessive Daytime Sleepiness, Parkinson's Disease
Phase 2CompletedBioprojet1082007-10-012012-06-11

Conditions studied

Disorders of Excessive Somnolence (3)  ·  Myotonic Dystrophy (1)  ·  Parkinson Disease (1)  ·  Prader-Willi Syndrome (1)  ·  Schizophrenia (1)  ·  Sleep Apnea, Obstructive (1)  ·  Sleep Wake Disorders (1)

Sponsors

Bioprojet (2)  ·  Harmony Biosciences Management, Inc. (2)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (3)  ·  France (2)  ·  Canada (1)

Top investigators

Carol A Tamminga, MD (1)  ·  Carsten Moeller (1)  ·  Evelyne De Paillette, MD (1)

Results publications

PMID 36790141, PMID 40605372